DXR Share Price Performance
US$12.96
4.21 (48.11%)
Price US$12.96
Share PriceUS$12.96
Daxor Corporation Stock Price
- 0 Narratives written by author
- 0 Comments on narratives written by author
- 0 Fair Values set on narratives written by author
DXR Community Narratives
There are no narratives available yet.
There are no community narratives available.
Snowflake Analysis
Daxor Corporation Key Details
Last Reported Earnings
Jun 30, 2025
Next Reporting Earnings
n/a
- 0.36
- 100.00%
- 2,710.84%
- 0.7%
About DXR
- Founded
- 1971
- Employees
- n/a
- CEO
- WebsiteView website
Daxor Corporation, a medical device company, provides blood volume measurement technology focused on blood volume testing. The company develops and markets BVA-100 Blood Volume Analyzer, a diagnostic blood test to provide safe, accurate, objective quantification of blood volume status and composition compared to patient-specific norms for used in a broad range of medical and surgical conditions. The company was formerly known as Idant Corporation and changed its name to Daxor Corporation in May 1973. Daxor Corporation was incorporated in 1971 and is headquartered in Oak Ridge, Tennessee. Daxor Corporation is a subsidiary of Estate Of Joseph Feldschuh.
